Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Sales of Property, Plant and Equipment (2010 - 2017)

Analysis

Exelixis (EXEL) Sales of Property, Plant and Equipment (2010 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.85 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 29, 2017 150,000.00
Jun 30, 2017 10,000.00
Mar 31, 2017 4,000.00
Dec 30, 2016 5,000.00
Sep 30, 2016 -20,000.00
Jun 30, 2016 5,000.00
Mar 31, 2016 107,000.00
Sep 30, 2015 5,000.00
Jun 30, 2015 656,000.00
Mar 31, 2015 639,000.00
Dec 31, 2014 106,000.00
Sep 30, 2014 5,000.00
Jun 30, 2014 5,000.00
Mar 31, 2014 276,000.00
Dec 31, 2013 103,000.00
Sep 30, 2013 40,000.00
Dec 31, 2012 1.07 Mn
Sep 30, 2012 18,000.00
Jun 30, 2012 12,000.00
Mar 31, 2012 847,000.00